• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度的新冠疫情:现状与未来的艰难攀升

COVID-19 Pandemic in India: Present Scenario and a Steep Climb Ahead.

作者信息

Pal Rimesh, Yadav Urmila

机构信息

Post Graduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

J Prim Care Community Health. 2020 Jan-Dec;11:2150132720939402. doi: 10.1177/2150132720939402.

DOI:10.1177/2150132720939402
PMID:32644871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7350042/
Abstract

Amid the ongoing COVID-19 pandemic, India has witnessed a massive surge of cases in the past 3 weeks. As of April 30, 33 610 confirmed cases and 1075 deaths have been reported from 32 states/union territories in India. Apart from the nationwide lockdown, India has increased its testing rate and has markedly strengthened the health care sector to combat COVID-19. With India's population of more than 1.3 billion people at a significant population density compared with the rest of the world, the lack of universal access to clean water and overall poor socioeconomic status, all have posed a major challenge to India's fight against COVID-19. Failure to contain the pandemic in India could have disastrous consequences with widespread cases and thousands of deaths that could easily overwhelm the health care infrastructure. Unabated spread of the pandemic could make India the next COVID-19 hotspot; hence the World Health Organization has recently stated that the "future of the pandemic will depend on how India handles it." Here, we have summarized the present scenario of the pandemic in India and the myriad challenges being faced by the country in its fight against COVID-19.

摘要

在持续的新冠疫情期间,印度在过去3周内病例数大幅激增。截至4月30日,印度32个邦/中央直辖区已报告33610例确诊病例和1075例死亡病例。除了全国范围的封锁措施外,印度提高了检测率,并显著加强了医疗保健部门以抗击新冠疫情。印度拥有超过13亿人口,与世界其他地区相比人口密度很大,缺乏普遍的清洁水供应以及整体社会经济状况不佳,所有这些都给印度抗击新冠疫情带来了重大挑战。若无法在印度控制疫情,可能会造成灾难性后果,病例广泛传播,数千人死亡,这很容易使医疗保健基础设施不堪重负。疫情的持续蔓延可能会使印度成为下一个新冠疫情热点地区;因此,世界卫生组织最近表示,“疫情的未来将取决于印度如何应对”。在此,我们总结了印度当前的疫情形势以及该国在抗击新冠疫情中面临的众多挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/7350042/f97ba74a2b61/10.1177_2150132720939402-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/7350042/f97ba74a2b61/10.1177_2150132720939402-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/7350042/f97ba74a2b61/10.1177_2150132720939402-fig1.jpg

相似文献

1
COVID-19 Pandemic in India: Present Scenario and a Steep Climb Ahead.印度的新冠疫情:现状与未来的艰难攀升
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720939402. doi: 10.1177/2150132720939402.
2
India's COVID-19 teacher.印度的新冠疫情教师。
Science. 2020 Nov 13;370(6518):752-753. doi: 10.1126/science.370.6518.752.
3
Gaps in India's preparedness for COVID-19 control.印度在新冠疫情防控准备方面的差距。
Lancet Infect Dis. 2020 May;20(5):544. doi: 10.1016/S1473-3099(20)30300-5. Epub 2020 Apr 17.
4
Why India needs to extend the nationwide lockdown.为何印度需要延长全国范围的封锁措施。
Am J Emerg Med. 2020 Jul;38(7):1528-1529. doi: 10.1016/j.ajem.2020.04.026. Epub 2020 Apr 15.
5
Lockdown is an effective 'vaccine' against COVID-19: A message from India.封锁是对抗新冠病毒的有效“疫苗”:来自印度的一则讯息。
J Infect Dev Ctries. 2020 Jun 30;14(6):545-546. doi: 10.3855/jidc.12931.
6
COVID-19: the end of lockdown what next?新冠疫情:封锁结束后,接下来会怎样?
Acta Biomed. 2020 May 11;91(2):236-238. doi: 10.23750/abm.v91i2.9605.
7
[Care Strategies and Trends in Taiwan During the COVID-19 Pandemic].[新冠疫情期间台湾地区的照护策略与趋势]
Hu Li Za Zhi. 2020 Dec;67(6):6-11. doi: 10.6224/JN.202012_67(6).02.
8
COVID-19 pandemic in India.印度的新冠疫情。
Eur Heart J. 2020 Oct 21;41(40):3874-3876. doi: 10.1093/eurheartj/ehaa493.
9
Lessons learnt during the first 100 days of COVID-19 pandemic in India.印度新冠疫情头100天期间汲取的经验教训。
Indian J Med Res. 2020 May;151(5):387-391. doi: 10.4103/ijmr.IJMR_1925_20.
10
India under COVID-19 lockdown.处于新冠疫情封锁下的印度。
Lancet. 2020 Apr 25;395(10233):1315. doi: 10.1016/S0140-6736(20)30938-7.

引用本文的文献

1
Impact of COVID-19 on Mental Health Among Healthcare Workers in India: A Mixed-methods Systematic Review.2019年冠状病毒病对印度医护人员心理健康的影响:一项混合方法的系统评价
Oman Med J. 2023 Sep 28;38(5):e544. doi: 10.5001/omj.2023.111. eCollection 2023 Sep.
2
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!基于mRNA的新冠疫苗:它们虽新但并非未知!
Vaccines (Basel). 2023 Feb 22;11(3):507. doi: 10.3390/vaccines11030507.
3
COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbionts.

本文引用的文献

1
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.医护人员与 SARS-CoV-2 在印度的感染:COVID-19 时期的病例对照研究。
Indian J Med Res. 2020 May;151(5):459-467. doi: 10.4103/ijmr.IJMR_2234_20.
2
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.纽约州 COVID-19 患者住院死亡率与羟氯喹或阿奇霉素治疗的关联。
JAMA. 2020 Jun 23;323(24):2493-2502. doi: 10.1001/jama.2020.8630.
3
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.
低收入人群与高收入人群中新冠病毒感染率的差异凸显了恢复真核共生生物已丧失生物多样性的必要性。
iScience. 2023 Mar 17;26(3):106167. doi: 10.1016/j.isci.2023.106167. Epub 2023 Feb 9.
4
Complications and Management of Retained Double-J Stents in Children During the Coronavirus Disease-2019 Pandemic.2019年冠状病毒病大流行期间儿童双J管残留的并发症及处理
J Indian Assoc Pediatr Surg. 2022 Nov-Dec;27(6):735-740. doi: 10.4103/jiaps.jiaps_67_22. Epub 2022 Nov 14.
5
An Analysis of the COVID-19 Situation in India in Terms of Testing, Treatment, Vaccine Acceptance and National Economic Performance.从检测、治疗、疫苗接种和国民经济表现方面分析印度的 COVID-19 形势。
Int J Public Health. 2022 Nov 2;67:1604975. doi: 10.3389/ijph.2022.1604975. eCollection 2022.
6
Role of multiresolution vulnerability indices in COVID-19 spread in India: a Bayesian model-based analysis.多分辨率脆弱性指数在印度 COVID-19 传播中的作用:基于贝叶斯模型的分析。
BMJ Open. 2022 Nov 17;12(11):e056292. doi: 10.1136/bmjopen-2021-056292.
7
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.清醒俯卧位对 COVID-19 合并急性呼吸衰竭患者经口气管插管的影响:一项随机临床试验。
JAMA. 2022 Jun 7;327(21):2104-2113. doi: 10.1001/jama.2022.7993.
8
Tuberculosis and COVID-19: A combined global threat to human civilization.结核病与新冠肺炎:对人类文明的全球性综合威胁。
Clin Epidemiol Glob Health. 2022 May-Jun;15:101031. doi: 10.1016/j.cegh.2022.101031. Epub 2022 Mar 27.
9
Surveillance of SARS-CoV-2 RNA in open-water sewage canals contaminated with untreated wastewater in resource-constrained regions.在资源受限地区受未经处理废水污染的露天污水渠中对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA进行监测。
Access Microbiol. 2022 Jan 18;4(1):000318. doi: 10.1099/acmi.0.000318. eCollection 2022.
10
A Comparative Retrospective Study of COVID-19 Responses in Four Representative Asian Countries.四个有代表性亚洲国家应对新冠疫情的比较回顾性研究
Risk Manag Healthc Policy. 2022 Jan 11;15:13-25. doi: 10.2147/RMHP.S334326. eCollection 2022.
羟氯喹治疗 COVID-19 住院患者的观察性研究。
N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.
4
Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach.印度控制 2019 年冠状病毒病传播的谨慎公共卫生干预策略:基于数学模型的方法。
Indian J Med Res. 2020;151(2 & 3):190-199. doi: 10.4103/ijmr.IJMR_504_20.
5
India under COVID-19 lockdown.处于新冠疫情封锁下的印度。
Lancet. 2020 Apr 25;395(10233):1315. doi: 10.1016/S0140-6736(20)30938-7.
6
Gaps in India's preparedness for COVID-19 control.印度在新冠疫情防控准备方面的差距。
Lancet Infect Dis. 2020 May;20(5):544. doi: 10.1016/S1473-3099(20)30300-5. Epub 2020 Apr 17.
7
Healthcare impact of COVID-19 epidemic in India: A stochastic mathematical model.印度新冠疫情的医疗保健影响:一个随机数学模型。
Med J Armed Forces India. 2020 Apr;76(2):147-155. doi: 10.1016/j.mjafi.2020.03.022. Epub 2020 Apr 2.
8
The COVID-19 Pandemic in the US: A Clinical Update.美国的新冠疫情:临床最新情况
JAMA. 2020 May 12;323(18):1767-1768. doi: 10.1001/jama.2020.5788.
9
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19:一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
10
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.